Spectrum (SPPI) Securities Lawsuit Seeks New Lead Plaintiff - Hagens Berman - PR Newswire
5 hours ago • Google News
Spectrum Pharmaceuticals Inc (SPPI)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 211.4M
P/E Ratio
0.00
Revenue (TTM)
$ 25.73M
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
2.14
Technicals
50-Day MA
1.015
200-Day MA
0.7748
52 Week High
N/A
52 Week Low
N/A
About SPPI
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
Employees
86
Headquarters
Boston, MA
CEO
Mr. Thomas J. Riga